SAGIMET BIOSCIENCES INC-A (SGMT) Forecast, Price Target & Analyst Ratings
NASDAQ:SGMT • US7867001049
5.41 USD
-0.04 (-0.73%)
At close: Mar 6, 2026
5.32 USD
-0.09 (-1.66%)
After Hours: 3/6/2026, 8:00:02 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SAGIMET BIOSCIENCES INC-A (SGMT).
Forecast Snapshot
Consensus Price Target
$25.96
+ 379.92% Upside
Next Earnings Forecast
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$0.41
Revenue Estimate
ChartMill Buy Consensus
84.44%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$25.96
Upside
+ 379.92%
From current price of $5.41 to mean target of $25.96, Based on 18 analyst forecasts
Low
$8.08
Median
$27.54
High
$38.85
Price Target Revisions
1 Month
-3.34%
3 Months
-3.34%
Price Target Summary
18 analysts have analysed SGMT and the average price target is 25.96 USD. This implies a price increase of 379.92% is expected in the next year compared to the current price of 5.41.
The average price target has been revised downward by 3.34% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
SGMT was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about SGMT.
In the previous month the buy percentage consensus was at a similar level.
SGMT was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-03 | Guggenheim | Initiate | Buy |
| 2026-02-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2026-01-28 | Barclays | Initiate | Equal-Weight |
| 2025-11-14 | Citizens | Maintains | Market Outperform -> Market Outperform |
| 2025-10-22 | Clear Street | Initiate | Buy |
| 2025-10-02 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-11 | Wedbush | Initiate | Outperform |
| 2025-07-24 | Canaccord Genuity | Initiate | Buy |
| 2025-06-06 | Jones Trading | Maintains | Buy -> Buy |
| 2025-03-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-27 | Jones Trading | Initiate | Buy |
| 2024-12-06 | Oppenheimer | Initiate | Outperform |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-12 | UBS | Initiate | Buy |
| 2024-10-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-15 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-01 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-06-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-07 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-06-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-24 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
Release DateMar 30, 2026
PeriodQ4 / 2025
EPS Estimate-$0.41
Revenue Estimate
Revenue Q2QN/A
EPS Q2Q17.01%
Number of Analysts12
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
3.94%
EPS (3 Months)
4.14%
Next Earnings Summary
SGMT is expected to report earnings on 3/30/2026. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2M | -100.00% | 113.332K | 5.24M 4,523.58% | 22.165M 323.00% | 24.429M 10.21% | 117.89M 382.58% | 248.61M 110.88% | 400.17M 60.96% | 477.24M 19.26% | ||||
| EBITDA YoY % growth | N/A | N/A | N/A | -57.282M -72.40% | -61.969M -8.18% | -73.236M -18.18% | -96.9M -32.31% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -23.719M -108.06% | -31.055M -30.93% | -30.74M 1.01% | -59.273M -77.14% | -62.111M -14.06% | -77.141M -24.20% | -97.32M -26.16% | -107.92M -10.89% | -112.06M -3.84% | -73.182M 34.69% | -29.244M 60.04% | 42.185M 244.25% | 183.11M 334.06% | |
| Operating Margin | N/A | N/A | -1,537.00% | N/A | N/A | -68,066.33% | -1,857.26% | -486.89% | -458.72% | -62.08% | -11.76% | 10.54% | 38.37% | |
| EPS YoY % growth | N/A | N/A | N/A | -1.60 91.31% | -1.72 -19.99% | -2.00 -16.39% | -2.29 -14.54% | -2.28 0.11% | -2.24 2.01% | -0.97 56.72% | 0.26 127.19% | 1.60 505.88% | 2.47 54.76% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.41 17.01% | -0.46 18.18% | -0.48 -50.96% | -0.55 -36.58% | -0.55 -32.80% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -14.688M | -13.872M | -15.81M | -21.114M -53.33% | N/A |
| EBIT Q2Q % growth | -15.564M 14.46% | -16.575M 16.56% | -16.966M -42.27% | -19.754M -37.81% | -20.4M -31.07% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-12.99%
EPS Next 5 Year
-9.38%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-17.80%
EBIT Next 5 Year
N/A
SAGIMET BIOSCIENCES INC-A / SGMT Forecast FAQ
What is the average price target for SAGIMET BIOSCIENCES INC-A (SGMT) stock?
18 analysts have analysed SGMT and the average price target is 25.96 USD. This implies a price increase of 379.92% is expected in the next year compared to the current price of 5.41.
Can you provide the upcoming earnings date for SAGIMET BIOSCIENCES INC-A?
SAGIMET BIOSCIENCES INC-A (SGMT) will report earnings on 2026-03-30, before the market open.
Can you provide the consensus estimates for SAGIMET BIOSCIENCES INC-A next earnings?
The consensus EPS estimate for the next earnings of SAGIMET BIOSCIENCES INC-A (SGMT) is -0.41 USD and the consensus revenue estimate is 0 USD.